Azithromycin Dihydrate
- Product NDC
- 70518-3501
- 11-digit product format
- 705183501
- Labeler code
- 70518
- Product ID
- 70518-3501_e76594d6-739a-5d57-e053-2a95a90a99af
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azithromycin Dihydrate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA208250
- Marketing category
- ANDA
- Marketing start
- 2022-08-29
- Marketing end
- 0000-00-00
- Substance
- AZITHROMYCIN DIHYDRATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Macrolide Antimicrobial [EPC], Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 70518-3501 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 70518-3501 | 70518-3501-0 | D | Discontinued by firm | 2026-08-03 | |
| excluded package | package | 70518-3501 | 70518-3501-1 | D | Discontinued by firm | 2026-08-03 | |
| excluded package | package | 70518-3501 | 70518-3501-2 | D | Discontinued by firm | 2026-08-03 | |
| excluded package | package | 70518-3501 | 70518-3501-3 | D | Discontinued by firm | 2026-08-03 | |
| excluded package | package | 70518-3501 | 70518-3501-4 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 70518-3501-1 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 70518-3501-2 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 70518-3501-0 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 70518-3501-4 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 70518-3501-1 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 70518-3501-2 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 70518-3501-0 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 70518-3501-4 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 70518-3501-2 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 70518-3501-2 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 70518-3501-2 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 70518-3501-2 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 70518-3501-2 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 70518-3501-2 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 70518-3501-2 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 70518-3501-2 | ad56d346431e… | cc804d4bbf1e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208250-001 | AZITHROMYCIN | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208250-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A208250-001 | AZITHROMYCIN | EQ 250MG BASE | TABLET / ORAL | AB | 2019-04-17 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A208250-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208250-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208250-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208250-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208250-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208250-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208250-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208250-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208250-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A208250-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208250-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208250-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208250-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A208250-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A208250-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A208250-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A208250-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A208250-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A208250-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A208250-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A208250-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A208250-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A208250-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A208250-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A208250-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A208250-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A208250-001 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208250-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A208250-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A208250-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A208250-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A208250-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A208250-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A208250-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A208250-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A208250-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A208250-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A208250-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A208250-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A208250-001 | AB | 1 | cb3db0bc1861… |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3501 | AZITHROMYCIN DIHYDRATE TABLET, FILM COATED [REMEDYREPACK INC.] | 4 | Legacy NDC | 20241010_efa7b126-71d2-43be-b3dc-32536217d308.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | PD-Rx Pharmaceuticals, Inc. | 7ab854bf-eb04-42c4-a403-096b60581bb4 | 2026-05-06 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Precision Dose, Inc. | d9b66736-3f1a-4d6d-bdc4-274f5adfb40c | 2026-04-14 | Warnings, Adverse reactions | 208250 ANDA208250 |
| AZITHROMYCIN | AZITHROMYCIN | DIRECT RX | a5b4092d-ab72-f5d1-e053-2995a90ac582 | 2026-03-17 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | REMEDYREPACK INC. | f0cfda1a-910f-4764-8658-263037df5ea8 | 2026-02-02 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Preferred Pharmaceuticals Inc. | b3c84aea-7ba7-4aae-999c-db740a9e53df | 2026-01-26 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | AvPAK | b635019e-7fd4-7f9e-e053-2a95a90a388c | 2026-01-08 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Redpharm Drug | 44f52ce0-ad3f-7d80-e063-6294a90ad086 | 2025-12-02 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | A-S Medication Solutions | df9b39b7-d42d-4c4b-b492-9fd228978dec | 2025-06-12 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | PD-Rx Pharmaceuticals, Inc. | e9800bbe-e8bf-4689-a8a5-dc23b5d2ee56 | 2025-03-26 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | TAGI Pharma, Inc. | 9f0501bf-d1c4-46a5-b253-3b9e61015e82 | 2025-03-07 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Coupler LLC | 2cc99fae-a72c-8893-e063-6394a90aa3ef | 2025-01-28 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Proficient Rx LP | a8e106cb-7245-45a5-9aad-bd624b1e011d | 2025-01-01 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Advanced Rx Pharmacy of Tennessee, LLC | f1752913-85ac-01fa-e053-2995a90a2bd8 | 2024-12-31 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | NuCare Pharmaceuticals Inc. | 258dd3c5-dce9-7483-e063-6294a90a4043 | 2024-12-26 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Quality Care Products, LLC | 2065c4ba-e3f5-41a2-b3d5-205dab646924 | 2024-12-19 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | A-S Medication Solutions | 1c84a68b-3eaa-4dab-b5e5-e195c7652e67 | 2024-06-14 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Proficient Rx LP | 8037c6f4-4881-4740-8229-2aee56141cd0 | 2022-05-01 | Warnings, Adverse reactions | 208250 ANDA208250 |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Asclemed USA, Inc. | b08bd8fc-20da-4623-9211-ae669452b16d | 2020-09-04 | Warnings, Adverse reactions | 208250 ANDA208250 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70518-3501-0 | 70518350100 | 6 TABLET, FILM COATED in 1 BLISTER PACK (70518-3501-0) | 2022-08-29 | 0000-00-00 | No | No | Current |
| 70518-3501-1 | 70518350101 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-3501-1) | 2022-08-29 | 0000-00-00 | No | No | Current |